Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963922 | Vaccine | 2015 | 5 Pages |
Abstract
HAV and HBV antibodies in half or more of this young PWID population did not have levels indicative of protection, and about a quarter had HCV infection, putting them at risk for complications resulting from co-infection with HAV or HBV. Programs serving this population should vaccinate PWIDs against HAV and HBV and not rely on self-report of vaccination.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Melissa G. Collier, Jan Drobeniuc, Jazmine Cuevas-Mota, Richard S. Garfein, Saleem Kamili, Eyasu H. Teshale,